surmount-1 trial tirzepatide weight loss nondiabetic SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, surmount-1 tirzepatide non-diabetic obesity weight
Pay in 4 interest-free payments of $6.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



























